Purchase Order 75D30125P20640
Award Date 9/19/25
Potential Completion Date 8/30/26
Potential Value $122K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30341, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Abbott Molecular Inc., a subsidiary of Abbott Laboratories, was awarded a firm fixed-price purchase order valued at $121,043.36 by the Centers for Disease Control and Prevention (CDC) on June 21, 2024, for delivery by February 1, 2025. The contract procures Abbott M2000 System equipment and related products from Abbott Molecular's Des Plaines, Illinois facility. The Abbott M2000 System is designated by the World Health Organization as the reference method for HIV viral load testing and early...
- This firm-fixed-price purchase order was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, for an estimated $100,800.00. The contract does not have a set-aside designation. Abbott Molecular, a manufacturer of molecular diagnostic products and services, will provide unspecified "other functions" to support the CDC's operations in Atlanta, Georgia. The award is not...
- The Centers for Disease Control and Prevention, within the Department of Health and Human Services, awarded Abbott Molecular Inc. a $143,595.78 firm fixed price call against the Abbott Laboratories GSA Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests. Under this short-term agreement lasting from August 1-15, 2023, Abbott Molecular will provide reagent kits to CDC for use in its disease prevention and health promotion efforts. As the prime contractor, Abbott Molecular will...
- This firm-fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, for the provision of reagents and kits for the ABBO. The contract has a ceiling value of $43,917.84 and a period of performance through August 15, 2024. This award is not associated with a set-aside program. Abbott Molecular is a global manufacturer of molecular diagnostic products and services, including COVID-19 test kits,...
- This is a delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, for HIV RNA extraction services. The firm-fixed-price contract, valued at $90,200.00, was awarded under the GSA Schedule for In-Vitro Diagnostics, Reagents, and Test Kits. The contract has an ultimate completion date of July 31, 2018 and is not designated as a set-aside contract. Abbott Molecular is a manufacturer of molecular diagnostic...
- This federal contract award is for the provision of reagents and consumables for use on the Abbott M2000SP and Abbott M2000RT molecular diagnostic platforms. The $121,338.60 contract was awarded to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, by the Department of Health and Human Services Centers for Disease Control and Prevention. The contract is a Blanket Purchase Agreement (BPA) call order under the GSA Schedule for In Vitro Diagnostics, Reagents, and Test (FSS-65-VII). No...
- This is a federal contract award to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, by the Centers for Disease Control and Prevention (CDC) Pittsburgh office. The contract is for the delivery of reagent kits, with a ceiling value of $87,060.00. It was awarded under the General Services Administration (GSA) Federal Supply Schedule (FSS) contract for Critical Analyzers, Laboratory (FSS-66-III), using a Firm Fixed Price pricing type. The contract has a performance period ending on...
- This is a federal contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Abbott Molecular Inc., a subsidiary of Abbott Laboratories. The contract is for the delivery of laboratory supplies, with a potential value of $134,274.88. The contract was issued as a Delivery Order under the GSA Schedule 65-VII contract for Invitro Diagnostics, Reagents, and Test. The contract does not have a set-aside designation. Abbott Molecular is a...
- <p>The Centers for Disease Control and Prevention awarded a purchase order to Abbott Molecular Inc. for a yearly service agreement for the Abbott Alinity M NAT System, with a ceiling value of $160,552.75, awarded June 15, 2023. Performance is located in Atlanta, Georgia, with an ultimate completion date of June 14, 2028. This firm fixed-price purchase order covers molecular diagnostic equipment and related services for infectious disease testing.</p>
- This is a federal contract award to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, to provide reagents and consumables for in-vitro diagnostics. The contract has a ceiling value of $82,161.09 and was awarded by the Centers for Disease Control and Prevention (CDC) in Pittsburgh. The contract is a delivery order under the GSA Schedule 65-VII for In-Vitro Diagnostics, Reagents, and Test Kits. It does not have a set-aside designation. Abbott Molecular is a large, for-profit manufacturer...